Source:http://linkedlifedata.com/resource/pubmed/id/20067264
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2010-2-4
|
pubmed:abstractText |
Illudin S and M (1, 2) are highly toxic sesquiterpenes found in the basidiomycete Omphalotus illudens. Illudins have a low therapeutic index, but acylfulvene derivatives display potent in vivo antitumor activity against a variety of multidrug resistant tumors. The lead acylfulvene (4), irofulven (5), in a randomized phase IIB clinical trial significantly increased overall survival in patients with metastatic hormone-refractory prostate cancer who failed prior treatment with two different standard chemotherapeutic regimens. Irofulven is unique, as the primary allylic hydroxyl group can undergo displacement with a variety of nucleophiles to produce analogues that retain key functional groups required for biological activity including the reactive cyclopropylmethyl carbinol and alpha,beta-unsaturated ketone. As described here, we synthesized a variety of urea, carbamate, and sulfonamide derivatives that retain key functional groups and display potent biological activity toward target solid tumor cells in vitro but are relatively nontoxic toward a nontarget B-cell derived cell line.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Carbamates,
http://linkedlifedata.com/resource/pubmed/chemical/Sesquiterpenes,
http://linkedlifedata.com/resource/pubmed/chemical/Spiro Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/Sulfonamides,
http://linkedlifedata.com/resource/pubmed/chemical/Urea,
http://linkedlifedata.com/resource/pubmed/chemical/acylfulvene
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1520-4804
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
11
|
pubmed:volume |
53
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1109-16
|
pubmed:meshHeading |
pubmed-meshheading:20067264-Adenocarcinoma,
pubmed-meshheading:20067264-Animals,
pubmed-meshheading:20067264-B-Lymphocytes,
pubmed-meshheading:20067264-Carbamates,
pubmed-meshheading:20067264-Cell Line,
pubmed-meshheading:20067264-Cell Survival,
pubmed-meshheading:20067264-Dose-Response Relationship, Drug,
pubmed-meshheading:20067264-Lung Neoplasms,
pubmed-meshheading:20067264-Mice,
pubmed-meshheading:20067264-Sesquiterpenes,
pubmed-meshheading:20067264-Spiro Compounds,
pubmed-meshheading:20067264-Structure-Activity Relationship,
pubmed-meshheading:20067264-Sulfonamides,
pubmed-meshheading:20067264-Urea
|
pubmed:year |
2010
|
pubmed:articleTitle |
Structure-activity studies of urea, carbamate, and sulfonamide derivatives of acylfulvene.
|
pubmed:affiliation |
Department of Chemistry and Biochemistry, University of California, San Diego, La Jolla, California 92093-0358, USA.
|
pubmed:publicationType |
Journal Article
|